Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effectiveness of Early Hemoperfusion in Patients With Extremely Severe COVID-19 After Intubation on a Ventilator

NCT06402279 is registered in ClinicalTrials.gov with Efferon JSC as lead sponsor.

NCT NCT06402279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06402279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effectiveness of Early Hemoperfusion in Patients With Extremely Severe COVID-19 After Intubation on a Ventilator
Lead sponsor
Efferon JSC
Phase
Observational
Overall status
Completed
Start date
October 1, 2020
Completion date
December 1, 2023
Enrollment
130 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19